<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39338094</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Mortality among Hospitalized Patients: Survival, Associated Factors, and Spatial Distribution in a City in São Paulo, Brazil, 2020.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1211</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph21091211</ELocationID><Abstract><AbstractText>The aims of this study were to analyze patient survival, identify the prognostic factors for patients with COVID-19 deaths considering the length of hospital stay, and evaluate the spatial distribution of these deaths in the city of Jundiaí, São Paulo, Brazil. We examined prognostic variables and survival rates of COVID-19 patients hospitalized at a reference hospital in Jundiaí, Brazil. A retrospective cohort of hospitalized cases from April to July of 2020 was included. Descriptive analysis, Kaplan-Meier curves, univariate and multivariate Cox regression, and binary logistic regression models were used. Among the 902 reported and confirmed cases, there were 311 deaths (34.5%). The median survival was 27 days, and the mean for those discharged was 46 days. Regardless of the length of hospital stay, desaturation, immunosuppression, age over 60, kidney disease, hypertension, lung disease, and hypertension were found to be independent predictors of death in both Cox and logistic regression models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batista</LastName><ForeName>Marília Jesus</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0379-3742</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Jundiaí Medical School, Jundiaí 13202-550, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lino</LastName><ForeName>Carolina Matteussi</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-6686-3296</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences and Child Dentistry, Faculty of Odontology of Piracicaba, University of Campinas, Piracicaba 13414-903, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tenani</LastName><ForeName>Carla Fabiana</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0001-7203-2763</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Jundiaí Medical School, Jundiaí 13202-550, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Adriano Pires</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Public Health, Jundiaí Medical School, Jundiaí 13202-550, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latorre</LastName><ForeName>Maria do Rosário Dias de Oliveira</ForeName><Initials>MDRDO</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Public Health, University of São Paulo, São Paulo 01246-904, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchi</LastName><ForeName>Evaldo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2131-5514</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Jundiaí Medical School, Jundiaí 13202-550, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002947" MajorTopicYN="N">Cities</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">public health</Keyword><Keyword MajorTopicYN="N">regression analysis</Keyword></KeywordList><CoiStatement>Authors declare they have no financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338094</ArticleId><ArticleId IdType="pmc">PMC11431193</ArticleId><ArticleId IdType="doi">10.3390/ijerph21091211</ArticleId><ArticleId IdType="pii">ijerph21091211</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Da Silva G.C. Análise de Sobrevivência dos Infectados pela COVID-19 no Estado do Rio Grande do Norte. Rev. Bras. Estud. Reg. Urbanos. 2021;15:156–182.</Citation></Reference><Reference><Citation>Coronavírus Brasil  Painel Geral.  [(accessed on 28 April 2023)];2022  Available online:  https://covid.saude.gov.br/</Citation></Reference><Reference><Citation>Mascarello K.C., Vieira A.C.B.C., Souza A.S.S., Marcarini W.D., Barauna V.G., Maciel E.L.N. COVID-19 hospitalization and death and relationship with social determinants of health and morbidities in Espírito Santo State, Brazil: A cross-sectional study. Epidemiol. Serviços Saúde. 2021;30:e2020919. doi: 10.1590/s1679-49742021000300004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1679-49742021000300004</ArticleId><ArticleId IdType="pubmed">34287551</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolzán A.G. Sobrevida en pacientes internados en unidades de cuidados intensivos por COVID-19 en la provincia de Buenos Aires, Argentina. Rev. Argent. Salud Pública. 2022;14:48.</Citation></Reference><Reference><Citation>Souza Filho Z.A., Nemer C.R.B., Teixeira E., Neves A.L.M., Nascimento M.H.M., Medeiros H.P. Fatores associados ao enfrentamento da pandemia da COVID-19 por pessoas idosas com comorbidades. Esc. Anna Nery. 2021;25:e20200495. doi: 10.1590/2177-9465-ean-2020-0495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2177-9465-ean-2020-0495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Liu Y.H., Wang C.Y., Wang Y.H., Hsueh S.C., Yen M.Y., Ko W.C., Hsueh P.R. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J. Microbiol. Immunol. Infect. 2020;53:404–412. doi: 10.1016/j.jmii.2020.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.02.012</ArticleId><ArticleId IdType="pmc">PMC7128959</ArticleId><ArticleId IdType="pubmed">32173241</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M., Aaron J.G., Claassen J., Rabbani L.E., Hastie J., et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. Lancet. 2020;395:1763–1770. doi: 10.1016/S0140-6736(20)31189-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31189-2</ArticleId><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>Fundação SEADE  Perfil dos Municípios Paulistas.  [(accessed on 28 April 2023)];2021  Available online:  http://perfil.seade.gov.br/#.</Citation></Reference><Reference><Citation>Prefeitura de Jundiaí  Coronavírus Jundiaí.  [(accessed on 28 April 2023)];2022  Available online:  https://jundiai.sp.gov.br/coronavirus/</Citation></Reference><Reference><Citation>Instituto Brasileiro de Geografia e Estatística  Censo 2010: Resultados Trabalho e Rendimento.  [(accessed on 28 April 2023)];2011  Available online:  https://www.ibge.gov.br/estatisticas/downloads-estatisticas.html.</Citation></Reference><Reference><Citation>Oliveira R.A., Neto M.S., Ferreira A.G.N., Pascoal L.M., Bezerra J.M., Dutra R.P., Pereira A.L.F. Fatores de risco e distribuição espacial dos óbitos por COVID-19: Revisão integrativa. Rev. Epidemiol. Controle Infecção. 2022;12 doi: 10.17058/reci.v12i1.17124.</Citation><ArticleIdList><ArticleId IdType="doi">10.17058/reci.v12i1.17124</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake T.M., Riad A.M., Fairfield C.J., Egan C., Knight S.R., Pius R., Hardwick H.E., Norman L., Shaw C.A., Thompson A.A.R., et al. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: A prospective, multicentre cohort study. Lancet. 2021;398:223–237. doi: 10.1016/S0140-6736(21)00799-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00799-6</ArticleId><ArticleId IdType="pmc">PMC8285118</ArticleId><ArticleId IdType="pubmed">34274064</ArticleId></ArticleIdList></Reference><Reference><Citation>OurWorldinData  Coronavirus (COVID-19) Vaccinations.  [(accessed on 28 April 2023)].  Available online:  https://ourworldindata.org/covid-vaccinations?country=OWID_WRL.</Citation></Reference><Reference><Citation>Hammerschmidt K.S.A., Santana R.F. Saúde do idoso em tempos de pandemia COVID-19. Cogitare Enferm. 2020;25:e72849. doi: 10.5380/ce.v25i0.72849.</Citation><ArticleIdList><ArticleId IdType="doi">10.5380/ce.v25i0.72849</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontes L., Danski M.T.R., Piubello S.M.N., Pereira J.d.F.G., Jantsch L.B., Costa L.B., Santos J.d.O.d., Arrué A.M. Perfil clínico e fatores associados ao óbito de pacientes COVID-19 nos primeiros meses da pandemia. Esc. Anna Nery. 2022;26:e20210203. doi: 10.1590/2177-9465-ean-2021-0203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2177-9465-ean-2021-0203</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Klein S.L., Garibaldi B.T., Li H., Wu C., Osevala N.M., Li T., Margolick J.B., Pawelec G., Leng S.X. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res. Rev. 2021;65:101205. doi: 10.1016/j.arr.2020.101205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101205</ArticleId><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvão M.H.R., Roncalli A.G. Fatores associados a maior risco de ocorrência de óbito por COVID-19: Análise de sobrevivência com base em casos confirmados. Rev. Bras. Epidemiol. 2020;23:E200106. doi: 10.1590/1980-549720200106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1980-549720200106</ArticleId><ArticleId IdType="pubmed">33439939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa E.L., Gaído S.B., Sousa R.A., Cardoso O.D., Matos E.M., Menezes J.M., Oliveira B.F., Aguiar B.G. Perfil de internações e óbitos hospitalares por síndrome respiratória aguda grave causada por COVID-19 no Piauí: Estudo descritivo, 2020–2021. Epidemiol. Serviços Saúde. 2022;31:e2021836. doi: 10.1590/s1679-49742022000100009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1679-49742022000100009</ArticleId><ArticleId IdType="pubmed">35476003</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y.-D., Ding M., Dong X., Zhang J.-J., Azkur A.K., Azkur D., Gan H., Sun Y.-L., Fu W., Li W., et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76:428–455. doi: 10.1111/all.14657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucholc M., Bradley D., Bennett D., Patterson L., Spiers R., Gibson D., Van Woerden H., Bjourson A.J. Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19. Sci. Rep. 2022;12:17313. doi: 10.1038/s41598-022-20176-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-20176-w</ArticleId><ArticleId IdType="pmc">PMC9568958</ArticleId><ArticleId IdType="pubmed">36243878</ArticleId></ArticleIdList></Reference><Reference><Citation>Berenguer J., Ryan P., Rodríguez-Baño J., Jarrín I., Carratalà J., Pachón J., Yllescas M., Arriba J.R., Muñoz E.A., Gil Divasson P., et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin. Microbiol. Infect. 2020;26:1525–1536. doi: 10.1016/j.cmi.2020.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.024</ArticleId><ArticleId IdType="pmc">PMC7399713</ArticleId><ArticleId IdType="pubmed">32758659</ArticleId></ArticleIdList></Reference><Reference><Citation>Du R.H., Liang L.R., Yang C.Q., Wang W., Cao T.Z., Li M., Guo G.Y., Du J., Zheng C.L., Zhu Q., et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: A prospective cohort study. Eur. Respir. J. 2020;55:2000524. doi: 10.1183/13993003.00524-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00524-2020</ArticleId><ArticleId IdType="pmc">PMC7144257</ArticleId><ArticleId IdType="pubmed">32269088</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanos A.H., Palaiodimou L., Zand R., Yaghi S., Kamel H., Navi B.B., Turc G., Romoli M., Sharma V., Mavridis D., et al. The impact of SARS-CoV-2 on stroke epidemiology and care: A meta-analysis. Ann. Neurol. 2021;89:380–388. doi: 10.1002/ana.25967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25967</ArticleId><ArticleId IdType="pmc">PMC7753413</ArticleId><ArticleId IdType="pubmed">33219563</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Self W.H., Semler M.W., Leither L.M., Casey J.D., Angus D.C., Brower R.G., Chang S.Y., Collins S.P., Eppensteiner J.C., Filbin M.R., et al. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: A randomized clinical trial. JAMA. 2020;324:2165–2176. doi: 10.1001/jama.2020.22240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22240</ArticleId><ArticleId IdType="pmc">PMC7653542</ArticleId><ArticleId IdType="pubmed">33165621</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group Dexamethasone in hospitalized patients with COVID-19. N. Engl. J. Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q., Ji R., Wang H., Wang Y., Zhou Y. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020;2020:91–95. doi: 10.1016/j.ijid.2020.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.017</ArticleId><ArticleId IdType="pmc">PMC7194638</ArticleId><ArticleId IdType="pubmed">32173574</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J.L., Navis G.J., Gordijn S.J., Bolling M.C., Dijkstra G., Voors A.A., Osterhaus A.D., et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) J. Pathol. 2020;251:228–248. doi: 10.1002/path.5471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5471</ArticleId><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo G., Calvez V., Savoia C. Hypertension and COVID-19: Current evidence and perspectives. High Blood Press. Cardiovasc. Prev. 2022;29:115–123. doi: 10.1007/s40292-022-00506-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-022-00506-9</ArticleId><ArticleId IdType="pmc">PMC8858218</ArticleId><ArticleId IdType="pubmed">35184271</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Liang W.H., Zhao Y., Liang H.R., Chen Z.S., Li Y.M., Liu X.Q., Chen R.C., Tang C.L., Wang T., et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur. Respir. J. 2020;55:2000547. doi: 10.1183/13993003.00547-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00547-2020</ArticleId><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637–1645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8084355</ArticleId><ArticleId IdType="pubmed">33933206</ArticleId></ArticleIdList></Reference><Reference><Citation>Karliner J., Slotterback S., Boyd R., Ashby N., Steele K. Health Care’s Climate Footprint: How the Health Sector Contributes to the Global Climate Crisis and Opportunities for Action.  [(accessed on 15 January 2022)].  Available online:  https://noharm-global.org/sites/default/files/documents-files/5961/HealthCaresClimateFootprint_092319.pdf.</Citation></Reference><Reference><Citation>National Institute for Health and Care Research Global Health Research Unit on Global Surgery Reducing the environmental impact of surgery on a global scale: Systematic review and co-prioritization with healthcare workers in 132 countries. Br. J. Surg. 2023;110:804–817. doi: 10.1093/bjs/znad092. Erratum in Br. J. Surg. 2023, 110, 1907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjs/znad092</ArticleId><ArticleId IdType="pmc">PMC10364528</ArticleId><ArticleId IdType="pubmed">37079880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirani M.R., Kowsari E., Teymourian T., Ramakrishna S. Environmental impact of increased soap consumption during COVID-19 pandemic: Biodegradable soap production and sustainable packaging. Sci. Total Environ. 2021;796:149013. doi: 10.1016/j.scitotenv.2021.149013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2021.149013</ArticleId><ArticleId IdType="pmc">PMC8272010</ArticleId><ArticleId IdType="pubmed">34271380</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia Y.A., El-Saadony M.T., Swelum A.A., Qattan S.Y.A., Al-Qurashi A.D., Asiry K.A., Shafi M.E., Elbestawy A.R., Gado A.R., Khafaga A.F., et al. COVID-19: Pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review. Environ. Sci. Pollut. Res. 2021;28:22241–22264. doi: 10.1007/s11356-021-13018-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-021-13018-1</ArticleId><ArticleId IdType="pmc">PMC7969349</ArticleId><ArticleId IdType="pubmed">33733422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J., Coupland C.A., Mehta N., Keogh R.H., Diaz-Ordaz K., Khunti K., Lyons R.A., Kee F., Sheikh A., Rahman S., et al. Risk prediction of COVID-19 related death and hospital admission in adults after COVID-19 vaccination: National prospective cohort study. BMJ. 2021;374:n2244. doi: 10.1136/bmj.n2244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2244</ArticleId><ArticleId IdType="pmc">PMC8446717</ArticleId><ArticleId IdType="pubmed">34535466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino C.M., Tenani C.F., Batista M.J. COVID-19 in Jundiaí/SP: Temporal dynamics of notifications and spatial analysis of seroepidemiological prevalence. Rev. Epidemiol. Controle Infecção. 2021;11:69–78.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>